New study reveals how well COVID-19 vaccines work in myeloma patients
NCT ID NCT05831787
First seen May 19, 2026 · Last updated May 19, 2026
Summary
This study looked at how well COVID-19 vaccines and boosters protect people with multiple myeloma, a blood cancer that weakens the immune system. Researchers enrolled 201 patients to track their vaccine history, booster uptake, and any side effects. The main goal was to see if it's possible to collect this information quickly and easily through online surveys and medical records. The findings help doctors understand how to better protect this vulnerable group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Memorial Sloan Kettering Cancer Center
New York, New York, 10065, United States
-
UNC-Chapel Hill
Chapel Hill, North Carolina, 27514, United States
Conditions
Explore the condition pages connected to this study.